Tela Bio (id:6739 TELA)
2.90 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 7:09:29 PM)
Exchange closed, opens in 14 hours 20 minutes
About Tela Bio
Market Capitalization 113.44M
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
| Headquarters (address) |
1 Great Valley Parkway Malvern 19355 PA United States |
| Phone | 484 320 2930 |
| Website | https://www.telabio.com |
| Employees | 227 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | TELA |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 2.30 - 7.84 |
| Market Capitalization | 113.44M |
| P/E trailing | -1.42 |
| P/E forward | -4.24 |
| Price/Sale | 1.65 |
| Price/Book | -11.42 |
| Beta | 0.968 |
| EPS | -1.69 |
| EPS United States (ID:6, base:3395) | 24.30 |